138 related articles for article (PubMed ID: 38206110)
21. Germline alterations in RASAL1 in Cowden syndrome patients presenting with follicular thyroid cancer and in individuals with apparently sporadic epithelial thyroid cancer.
Ngeow J; Ni Y; Tohme R; Song Chen F; Bebek G; Eng C
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1316-21. PubMed ID: 24712574
[TBL] [Abstract][Full Text] [Related]
22. Multiple sclerotic fibromas of the skin. A cutaneous marker of Cowden's disease.
Requena L; Gutiérrez J; Sánchez Yus E
J Cutan Pathol; 1992 Aug; 19(4):346-51. PubMed ID: 1430474
[TBL] [Abstract][Full Text] [Related]
23. Novel PTEN mutation in Cowden syndrome: case report with late diagnosis and non-malignant course.
Martínez-Doménech A; García-Legaz Martínez M; Magdaleno-Tapial J; Pérez-Pastor G; Rodríguez-López R; Pérez-Ferriols A
Dermatol Online J; 2019 May; 25(5):. PubMed ID: 31220904
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer.
Agrawal S; Eng C
Hum Mol Genet; 2006 Mar; 15(5):777-87. PubMed ID: 16436456
[TBL] [Abstract][Full Text] [Related]
25. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?
Mester JL; Moore RA; Eng C
Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976
[TBL] [Abstract][Full Text] [Related]
26. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
[TBL] [Abstract][Full Text] [Related]
27. Acral Plexiform Palisaded Encapsulated Neuromas as the Initial Cutaneous Manifestation of Cowden Syndrome.
Harris E; Mir A
Pediatr Dermatol; 2017 Jul; 34(4):e219-e220. PubMed ID: 28543709
[TBL] [Abstract][Full Text] [Related]
28. Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.
Banneau G; Guedj M; MacGrogan G; de Mascarel I; Velasco V; Schiappa R; Bonadona V; David A; Dugast C; Gilbert-Dussardier B; Ingster O; Vabres P; Caux F; de Reynies A; Iggo R; Sevenet N; Bonnet F; Longy M
Breast Cancer Res; 2010; 12(4):R63. PubMed ID: 20712882
[TBL] [Abstract][Full Text] [Related]
29. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.
Pilarski R; Burt R; Kohlman W; Pho L; Shannon KM; Swisher E
J Natl Cancer Inst; 2013 Nov; 105(21):1607-16. PubMed ID: 24136893
[TBL] [Abstract][Full Text] [Related]
30. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.
Laury AR; Bongiovanni M; Tille JC; Kozakewich H; Nosé V
Thyroid; 2011 Feb; 21(2):135-44. PubMed ID: 21190448
[TBL] [Abstract][Full Text] [Related]
31. Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cells.
Yu W; Ni Y; Saji M; Ringel MD; Jaini R; Eng C
Hum Mol Genet; 2017 Apr; 26(7):1365-1375. PubMed ID: 28164237
[TBL] [Abstract][Full Text] [Related]
32. Multiple primary malignancies and subtle mucocutaneous lesions associated with a novel PTEN gene mutation in a patient with Cowden syndrome: case report.
Vasovčák P; Senkeříková M; Hatlová J; Křepelová A
BMC Med Genet; 2011 Mar; 12():38. PubMed ID: 21406108
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report.
Neychev V; Sadowski SM; Zhu J; Allgaeuer M; Kilian K; Meltzer P; Kebebew E
J Clin Endocrinol Metab; 2016 Feb; 101(2):353-8. PubMed ID: 26678657
[TBL] [Abstract][Full Text] [Related]
34. Multiple colon carcinomas in a patient with Cowden syndrome.
Bosserhoff AK; Grussendorf-Conen EI; Rübben A; Rudnik-Schöneborn S; Zerres K; Buettner R; Merkelbach-Bruse S
Int J Mol Med; 2006 Oct; 18(4):643-7. PubMed ID: 16964417
[TBL] [Abstract][Full Text] [Related]
35. Identification of a Cowden syndrome patient with a novel PTEN mutation and establishment of patient-derived induced pluripotent stem cells.
Obayashi F; Hamada A; Yamasaki S; Kanda T; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):69-78. PubMed ID: 34984555
[TBL] [Abstract][Full Text] [Related]
36. Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through SRC-induced PTEN oxidation.
Yu W; He X; Ni Y; Ngeow J; Eng C
Hum Mol Genet; 2015 Jan; 24(1):142-53. PubMed ID: 25149476
[TBL] [Abstract][Full Text] [Related]
37. A novel mutation of the PTEN gene in a Japanese patient with Cowden syndrome and bilateral breast cancer.
Tate G; Suzuki T; Endo Y; Mitsuya T
Cancer Genet Cytogenet; 2008 Jul; 184(1):67-71. PubMed ID: 18558293
[TBL] [Abstract][Full Text] [Related]
38. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
Ngeow J; Stanuch K; Mester JL; Barnholtz-Sloan JS; Eng C
J Clin Oncol; 2014 Jun; 32(17):1818-24. PubMed ID: 24778394
[TBL] [Abstract][Full Text] [Related]
39. Analysis of PTEN gene mutations in a Turkish patient with Cowden syndrome.
Soysal Y; Tate G; Polat C; Polat N; Aktepe F; Sivaci Y; Imirzalioglu N
Genet Test Mol Biomarkers; 2009 Aug; 13(4):547-51. PubMed ID: 19604110
[TBL] [Abstract][Full Text] [Related]
40. Management of reproductive health in Cowden syndrome complicated by endometrial polyps and breast cancer.
Kalin A; Merideth MA; Regier DS; Blumenthal GM; Dennis PA; Stratton P
Obstet Gynecol; 2013 Feb; 121(2 Pt 2 Suppl 1):461-464. PubMed ID: 23344409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
